Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Colli LG"'
Autor:
Machado NR; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1524, 3o Floor, Room 319, Butanta, SP, 05508000, Brazil., Miyazaki MA; Department of Surgery, Division of Urology, Human Reproduction Section, São Paulo Federal University, São Paulo, Brazil., Oliveira TD; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1524, 3o Floor, Room 319, Butanta, SP, 05508000, Brazil., Dias KT; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1524, 3o Floor, Room 319, Butanta, SP, 05508000, Brazil., Colli LG; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1524, 3o Floor, Room 319, Butanta, SP, 05508000, Brazil., Belardin LB; Department of Surgery, Division of Urology, Human Reproduction Section, São Paulo Federal University, São Paulo, Brazil., Bertolla RP; Department of Surgery, Division of Urology, Human Reproduction Section, São Paulo Federal University, São Paulo, Brazil.; Department of Obstetrics and Gynecology, School of Medicine, C.S. Mott Center for Human Growth and Development, Wayne State University, Detroit, MI, USA., Rodrigues SF; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes 1524, 3o Floor, Room 319, Butanta, SP, 05508000, Brazil. stephen.rodrigues@usp.br.
Publikováno v:
Scientific reports [Sci Rep] 2024 Nov 20; Vol. 14 (1), pp. 28808. Date of Electronic Publication: 2024 Nov 20.
Autor:
Silva VCJD; Laboratory of Vascular Nanopharmacology, Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil., Silva RNO; Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil., Colli LG; Laboratory of Hypertension, Diabetes and Vascular Biology, Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil., Carvalho MHC; Laboratory of Hypertension, Diabetes and Vascular Biology, Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil., Rodrigues SF; Laboratory of Vascular Nanopharmacology, Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil.; Laboratory of Hypertension, Diabetes and Vascular Biology, Department of Pharmacology, Institute of Biomedical Sciences I, University of Sao Paulo, Sao Paulo, SP, Brazil.
Publikováno v:
Heliyon [Heliyon] 2020 Nov 25; Vol. 6 (11), pp. e05591. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Autor:
Colli LG; Department of Pharmacology, Division of Vascular Biology, Hypertension Section, Instituto de Ciências Biomédicas, Universidade de São Paulo -ICB/USP, São Paulo, SP, Brazil. lucas_colli@hotmail.com., Belardin LB; Department of Surgery, Division of Urology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil., Echem C; Department of Pharmacology, Division of Vascular Biology, Hypertension Section, Instituto de Ciências Biomédicas, Universidade de São Paulo -ICB/USP, São Paulo, SP, Brazil., Akamine EH; Department of Pharmacology, Division of Vascular Biology, Hypertension Section, Instituto de Ciências Biomédicas, Universidade de São Paulo -ICB/USP, São Paulo, SP, Brazil., Antoniassi MP; Department of Surgery, Division of Urology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil., Andretta RR; Department of Surgery, Division of Urology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil., Mathias LS; Department of Internal Medicine, Botucatu Medical University, Universidade Estadual Paulista - UNESP, Botucatu, São Paulo, Brazil., Rodrigues SFP; Department of Pharmacology, Division of Vascular Biology, Hypertension Section, Instituto de Ciências Biomédicas, Universidade de São Paulo -ICB/USP, São Paulo, SP, Brazil., Bertolla RP; Department of Surgery, Division of Urology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil. rbertolla@yahoo.com., de Carvalho MHC; Department of Pharmacology, Division of Vascular Biology, Hypertension Section, Instituto de Ciências Biomédicas, Universidade de São Paulo -ICB/USP, São Paulo, SP, Brazil. mhcarval@icb.usp.br.
Publikováno v:
Scientific reports [Sci Rep] 2019 Jul 30; Vol. 9 (1), pp. 11047. Date of Electronic Publication: 2019 Jul 30.
Autor:
Araujo PX; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Costa TJ; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Echem C; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Aparecida de Oliveira M; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Santos-Eichler RA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Colli LG; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Jiménez-Altayó F; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Vila E; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Akamine EH; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.)., Dantas AP; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.) mhcarval@icb.usp.br gsceravolo@uel.br adantas@clinic.ub.es., Ceravolo GS; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.) mhcarval@icb.usp.br gsceravolo@uel.br adantas@clinic.ub.es., de Carvalho MHC; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil. (P.X.A., T.J.C., C.E., M.A.O., R.A.S.E., L.G.C., E.H.A., M.H.C.C.); Department of Physiological Sciences, State University of Londrina, Londrina, Brazil. (G.S.C.), Facultat de Medicina, Departament de Farmacologia, Terapèutica i Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain. (F.J.-A., E.V.); Group of Atherosclerosis and Coronary disease, Institut Clinic del Torax, Institut d'Investigaciones Biomédiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. (A.P.D.) mhcarval@icb.usp.br gsceravolo@uel.br adantas@clinic.ub.es.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2017 Jul; Vol. 362 (1), pp. 98-107. Date of Electronic Publication: 2017 May 22.